Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-24-030839

CEO and Director acquired 84,932 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Meckler Jeffrey A CEO and Director 2024-08-08 Grant or award +84,932 $1.83 $155,001 160,306 D
Derivatives
Meckler Jeffrey A CEO and Director 2024-08-08 Grant or award · Common Stock Warrants +84,932 $1.83 $155,001 84,932 D
Loading xslF345X05/ownership.xml…